LEADING PHARMA LLC FDA Approval ANDA 214949

ANDA 214949

LEADING PHARMA LLC

FDA Drug Application

Application #214949

Application Sponsors

ANDA 214949LEADING PHARMA LLC

Marketing Status

Prescription001

Application Products

001FOR SUSPENSION;ORALEQ 6MG BASE/ML0OSELTAMIVIR PHOSPHATEOSELTAMIVIR PHOSPHATE

FDA Submissions

UNKNOWN; ORIG1AP2022-02-28STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

LEADING PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214949
            [companyName] => LEADING PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"OSELTAMIVIR PHOSPHATE","activeIngredients":"OSELTAMIVIR PHOSPHATE","strength":"EQ 6MG BASE\/ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/28\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-02-28
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.